HUTCHMED is a China-based biopharmaceutical company that develops and commercializes drugs for the treatment of cancer and immunological diseases.
Business Model:
Revenue: $356.1M
Employees: 1,001-5,000
Address: 2 Queen's Road Central
City: Hong Kong
State: other
Zip:
Country: HK
HUTCHMED is a China-based biopharmaceutical company that develops and commercializes drugs for the treatment of cancer and immunological diseases.
Contact Phone:
Contact Email:
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
6/30/2021
Ticker Symbol:
13
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2020 | Post-IPO Equity | 1 | $100M |
Canada Pension Plan Investment Board Canada Pension Plan Investment Board Canada Pension Plan Investment Board Canada Pension Plan Investment Board |
12/2010 | Venture Round | 1 | $7.7M |
SBCVC SBCVC SBCVC SBCVC |
6/2020 | Post-IPO Equity | 1 | $100M |
General Atlantic General Atlantic General Atlantic General Atlantic |
11/2010 | Venture Round | 1 | $12.5M |
Mitsui &a; Co Mitsui &a; Co Mitsui &a; Co Mitsui &a; Co |
4/2021 | Private Placement | $100M | 6/2021 | IPO | $537M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|